Now I have verified all claims against the paper. Let me produce the consolidated review.

## Summary

EquiJump introduces a two-sided stochastic interpolant framework for all-atom protein dynamics simulation, directly bridging consecutive 100 ps MD snapshots via SO(3)-equivariant neural networks. Rather than transporting from a Gaussian prior (as in standard diffusion/flow models), the source distribution is the current conformation and the target is the next conformation, keeping the latent space close to the data manifold. A single transferable model is trained across 12 fast-folding proteins and evaluated on long-timescale dynamics through MSM-reweighted observables.

## Strengths

1. **Direct two-sided transport between consecutive MD timesteps is well motivated and demonstrably superior.** The paper formalizes why bridging ρ₀ = ρ(Xᵗ) and ρ₁ = ρ(Xᵗ⁺¹∣Xᵗ) keeps the latent space close to the data manifold (Section 3.2, Figure 2c). Table 1 shows EquiJump achieves JS divergences 5–10× lower than DDPM, Flow Matching, and one-sided interpolants on Protein G (e.g., TIC1 JS = 0.004 vs. 0.022 for the best one-sided method).

2. **A single transferable model recovers dynamics across all 12 fast-folding proteins with substantially higher accuracy than the only available multi-protein baseline.** At H=256, EquiJump averages JS of 0.03 (TIC1) and 0.03 (TIC2) across 12 proteins, versus 0.30 and 0.23 for CG-MLFF (Table 2). Percent error in ensemble averages (Table 3) shows similar improvements (e.g., RMSD 15.2% vs. 34.7%). Figure 6 provides per-protein free energy maps confirming the trend.

3. **Measurable acceleration over explicit-solvent classical MD with a documented accuracy–speed trade-off.** Table 4 reports that even the largest model (391M params) achieves 3.4–4.5× acceleration on the lambda protein relative to Amber24 explicit-solvent simulations, while Figure 6 shows models with 5–15× acceleration keep TIC JS below 0.1. The comparison to MACE-OFF23 (estimated 0.004× slowdown) contextualizes the advantage.

4. **Efficient architecture design with τ-independent conditioner.** The four-track design (conditioner + 4 headers) avoids recomputing the source embedding at every inner integration step (Algorithms 1–2, Figure 3d). While not ablated, the design rationale is clearly stated and the computational benefit is plausible.

## Weaknesses

### Fatal
None.

### Major

1. **The MSM reweighting procedure that underlies all quantitative results is not validated.** The paper's central claims (Tables 1–3, Figures 3, 6) depend on reweighting generated samples toward the stationary distribution via TICA + k-means + Markov State Models. The paper itself acknowledges (Section 4.2) that "this reweighing is extremely sensitive to the correct description of the transition states," yet provides no validation that the reference MSM is well-specified. No implied timescales, no Chapman–Kolmogorov test, no robustness analysis with respect to number of clusters or lag time are presented. Without this, the reported JS divergences measure fidelity to the MSM's representation of the dynamics—not necessarily to the true physical dynamics. If the reference MSM smooths over or misses important slow modes, the favorable numbers could be misleading. This is the most significant evidential gap in the paper.

### Minor

2. **No error bars or confidence intervals on any quantitative result.** Tables 1–3 report only point estimates of JS divergence. While the trends in Table 1 are large enough to be robust, the differences between model sizes in Tables 2–3 (e.g., TIC1: 0.07 for H=128 vs. 0.03 for H=256) cannot be assessed for statistical significance. Reporting means ± std from multiple runs or bootstrap resampling over trajectories would substantially strengthen the empirical claims.

3. **Acceleration comparison conflates representation coarsening with algorithmic speedup.** Table 4 compares EquiJump (protein heavy atoms only, no solvent) against Amber24 explicit-solvent MD (~12,000 atoms including water). The reported acceleration factors therefore reflect skipping solvent degrees of freedom in addition to any algorithmic advantage. The paper is transparent about the reference being explicit-solvent Amber24, but the framing (e.g., "5–15× acceleration compared to Amber24") implicitly promises a comparison at the same level of fidelity. A comparison against implicit-solvent MD, or against the cost of evolving only the protein degrees of freedom in the original MD, would be more informative. This does not invalidate the practical value of the speedup, but the acceleration numbers should be scoped more carefully.

4. **"State-of-the-art" claim is scoped too broadly.** The abstract claims "state-of-the-art results on dynamics simulation." For the transferable model, this is defensible against CG-MLFF (the only other multi-protein baseline). For general dynamics simulation, the generative transport comparison (Section 4.3) covers DDPM, Flow Matching, and one-sided interpolants but is limited to one protein (Protein G). Broader per-protein deep learning methods such as ITO, Timewarp, or F³low are discussed in related work but not directly compared on the multi-protein benchmark. The claim would be more precise if scoped to "state-of-the-art for transferable all-atom dynamics simulation on the fast-folding protein benchmark."

5. **The τ-independent conditioner design choice is not ablated.** The paper states (Section 3.4) that the conditioner is made independent of τ "for efficiency," but provides no empirical comparison against an alternative that conditions on τ and uses simpler headers. A brief ablation on Protein G would justify this design decision.

6. **Wide MSM lag time range (45–95 ns) without justification.** The transition matrix for the MSM is estimated using a lag time of 45–95 ns, which spans more than a factor of two. The paper does not explain how this range was chosen, whether results are sensitive to the specific value, or whether the implied timescales are converged within this window.

7. **No discussion of limitations.** The paper lacks a limitations section. It does not address that the model excludes solvent, hydrogens, and environmental effects; that the 13-heavy-atom-per-residue padding may lose information for larger residues (e.g., tryptophan); or that the representation is tied to the specific dataset. A brief discussion would improve scientific completeness without weakening the contribution.

8. **No structural validity checks on generated conformations.** The dihedral distributions (Figure 5) and free energy landscapes (Figure 6) suggest the model produces physically reasonable conformations, but there is no explicit check for steric clashes, bond-length/bond-angle violations, or other unphysical geometries. This is not a fatal omission—the dihedral validation is partial evidence—but an explicit structural validity analysis would increase confidence.

### Trivial
None.

## Nice-to-Haves

- An ablation study of the number of integration steps (currently fixed at 100) vs. sample quality would quantify another dimension of the accuracy–speed trade-off.
- Per-protein breakdown of the JS divergences in Tables 2–3 (rather than only averages) would help identify which proteins are harder for EquiJump.
- Brief comment on the per-protein variation visible in Figure 6 (e.g., BBA shows noticeable mismatch) would improve the discussion.

## Removed Points

These points were removed from the original reviews with justification:

1. **"The hyperparameters (number of clusters, number of TIC components) are not given."** — The paper explicitly states (Section 4.2): "cluster the configuration using K-means in the first 4 TIC dimensions with 100 clusters." The hyperparameters are given.
2. **"The paper should add more baselines beyond CG-MLFF for the transferable model."** — The paper explicitly notes that CG-MLFF "is the only other multi-protein model that covers the 12 fast-folding proteins" (Section 4.3). Demanding baselines that do not exist is not a valid weakness.
3. **Generic strengths from Strength Finder** — Any strengths that were generic or lacked specific support (none in this case; all listed strengths had specific citations) were retained. All strength finder items were concrete and evidence-backed.
4. **Formatting/style nitpicks** — None present in the actual reviews.

## Novel Insights

Beyond the paper's own contributions, the most novel observation emerging from the reviews is the tension between the paper's reliance on MSM reweighting for evaluation and the inherent sensitivity of that procedure. The paper acknowledges this sensitivity in a single sentence but then uses the MSM outputs as ground truth without validation. This creates an epistemic gap: the reader cannot distinguish whether EquiJump truly captures the slow dynamics or whether the MSM simply smooths over errors in a way that makes all methods look comparable to a smoothed reference. This observation is independent of whether the MSM validation would ultimately pass—it is about the evidential structure of the paper's core claims.

## Suggestions

1. **Validate the MSM.** Add an appendix with implied timescales plots, Chapman–Kolmogorov tests for a subset of proteins, and robustness analysis to the number of clusters and lag time. This single addition would significantly increase confidence in all quantitative results.
2. **Add error bars.** Report JS divergences from multiple training seeds or bootstrap over trajectory subsets for Tables 1–3.
3. **Re-frame acceleration comparisons.** Either compare against the cost of evolving only protein degrees of freedom in the reference MD, or add a clear caveat that the speedup reflects both algorithmic gains and the absence of solvent.
4. **Scope "state-of-the-art" more precisely.** Replace the broad phrasing with "state-of-the-art for transferable all-atom dynamics simulation on the 12 fast-folding protein benchmark."
5. **Add a brief limitations section** covering the key exclusions (solvent, hydrogens, residue-size padding, dataset specificity).

## Score and Decision

This is a technically solid paper with a well-motivated method and promising results. The core contributions—two-sided stochastic interpolants for dynamics simulation, the SO(3)-equivariant architecture, and the transferable model across 12 proteins—are novel and the evidence for the generative transport improvement is strong (Table 1). The main weaknesses are the unvalidated MSM reweighting (the most significant issue), the absence of error bars, and the imprecise scoping of the acceleration and SOTA claims. All are addressable with revisions. The MSM validation is the one issue that could change the credibility of the results if it reveals problems—this is what keeps the paper from a stronger score.

MY FINAL SCORE: <pineapple>6.0</pineapple>
MY FINAL DECISION: <orange>Accept</orange>